Dermatomyositis+1
RecruitingStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
- Disease:DermatomyositisPolymyositis
Hungary- Participants:18–64 years · 65+ years
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
HungaryStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
HungaryStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
HungaryStudy on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases
HungaryStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
HungaryA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
HungaryStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
HungaryStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
HungaryStudy on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping
HungaryStudy on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease
Hungary